Common Questions About Using ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast
What is lobular carcinoma in situ?
Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells grow in the lobules of the breast. While it is not considered breast cancer, it indicates an increased risk for developing invasive breast cancer in the future.
How is lobular carcinoma in situ diagnosed?
LCIS is typically diagnosed through a breast biopsy, often performed after an abnormal mammogram or clinical examination. It may be discovered incidentally during the evaluation of other breast conditions.
What are the treatment options for lobular carcinoma in situ?
Management of LCIS usually involves regular monitoring and surveillance rather than immediate treatment. Patients may be advised on lifestyle changes and risk-reducing strategies.
Is lobular carcinoma in situ hereditary?
While LCIS itself is not hereditary, it is associated with genetic factors that may increase breast cancer risk. Family history should be evaluated to determine the need for genetic counseling.
Clinical Notes
SOAP notes
DAP notes
AI medical notes